Showing results (351-360 of 567) with videos related to
Sort By:
Pageof 57
Journal of the American Academy of Dermatology|September 24, 2018
A provider global assessment quality measure for clinical practice for inflammatory skin disordersAlice Gottlieb, Nicole Salame, April W Armstrong, et al.JAMA Dermatology|May 26, 2021
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin DiseasesMaria C Schneeweiss, Seoyoung C Kim, Richard Wyss, et al.Annals of the Rheumatic Diseases|May 23, 2019
The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studiesArthur Kavanaugh, Alice Gottlieb, Akimichi Morita, et al.Journal of Medical Economics|May 3, 2018
Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severityMwangi J Murage, Amanda Anderson, Susan A Oliveria, et al.Current Rheumatology Reports|September 22, 2020
Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMANStacie Bell, Joseph F Merola, Dan E Webster, et al.The Journal of Rheumatology|July 15, 2023
Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual MeetingMelissa P Zundell, Michael J Woodbury, Kathryn Lee, et al.The Journal of Rheumatology|April 2, 2022
Report of the Skin Research Working Groups from the GRAPPA 2021 Annual MeetingJenna E Yousif, Joseph F Merola, Lourdes M Perez-Chada, et al.Frontiers in Medicine|February 13, 2023
Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetesAlexander Egeberg, Joseph F Merola, Knut Schäkel, et al.Frontiers in Medicine|March 28, 2023
Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetesAlexander Egeberg, Joseph F Merola, Knut Schäkel, et al.Clinical and Experimental Dermatology|May 11, 2024
Impact of disease, musculoskeletal symptoms and disease control in the CorEvitas Psoriasis RegistryCarly Grant, Lourdes M Perez-Chada, Ryan W Harrison, et al.Pageof 57